DepoMed (DEPO) PT Lowered to $21 at Piper Jaffray

May 6, 2016 9:09 AM

Piper Jaffray analyst David Amsellem lowered his price target on DepoMed Inc (NASDAQ: DEPO) to $21.00 (from $23.00) and reiterated ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found